Baylor University Medical Center Proceedings April 2014, Volume 27, Number 2 | Page 113

169. Sobrino J, Barnes SA, Dahr N, Kudyakov R, Berryman C, Nathens
AB, Hemmila MR, Neal M, Shafi S. Frequency of adoption of practice
management guidelines at trauma centers. Proc (Bayl Univ Med Cent)
2013;26(3):256–261.
170. Sobrino J, Shafi S. Timing and causes of death after injuries. Proc (Bayl
Univ Med Cent) 2013;26(2):120–123.
171. Staggers N, Xiao Y, Chapman L. Debunking health IT usability myths.
Appl Clin Inform 2013;4(2):241–250.

188.

189.
190.

HEPATOLOGY
Note: See also Transplantation.
172. Asrani SK, Kamath PS. Natural history of cirrhosis. Curr Gastroenterol
Rep 2013;15(2):308.
173. Asrani SK, Larson JJ, Yawn B, Therneau TM, Kim WR. Underestimation of liver-related mortality in the United States. Gastroenterology
2013;145(2):375–382.e1–2.
174. Asrani SK, Talwalkar JA, Kamath PS, Shah VH, Saracino G, Jennings L,
Gross JB, Venkatesh S, Ehman RL. Role of magnetic resonance elastography in compensated and decompensated liver disease. J Hepatol 2013
Dec 19 [Epub ahead of print].
175. Asrani SK, Warnes CA, Kamath PS. Hepatocellular carcinoma after the
Fontan procedure. N Engl J Med 2013;368(18):1756–1757.
176. Gonzalez SA. Acute Liver Failure: Diagnosis and Management (BMJ Point
of Care Monograph), 4th ed. London: BMJ Group, 2013. Available at
https://online.epocrates.com/home.
177. Gonzalez SA. Future directions in hepatitis C therapy. In Emerging
Therapeutic Options for Hepatitis C. London: Future Science Group,
2013:98–111.
178. Rahimi RS, Elliott AC, Rockey DC. Altered mental status in cirrhosis:
etiologies and outcomes. J Investig Med 2013;61(4):695–700.
179. Rahimi RS, Landaverde C. Nonalcoholic fatty liver disease and the
me F&